Heparin-induced Thrombocytopenia

Heparin-induced Thrombocytopenia (HIT) is a potentially life-threatening side effect of the drug heparin, an anticoagulant used to prevent clots in medical conditions such as deep vein thrombosis. HIT occurs when antibodies in the body recognize heparin as a foreign substance and become activated. This triggers an immune response that destroys platelets and leads to a dramatic drop in the number of platelets in the blood, leading to a heightened risk of bleeding or clotting. HIT can be effectively managed with careful monitoring and early diagnosis, allowing patients to continue to receive heparin safely.

← Journal of Drug Resistant Pathogen Research

Related Articles

2 article(s) found

Immune Thrombocytopenia after Allogeneic Stem Cell Transplantation: Case Report and Brief Overview of Treatment Strategies

Full-text HTML Download PDF Download XML

Laboratory Tests Used in the Diagnosis of Immune Thrombocytopenia and General Treatment Approaches

Full-text HTML Download PDF Download XML